Learn more
Log in
0 followers
Rafael Holdings (NYSE: RFL) is focused on the development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies-- Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd.
Industries
Headquarters
Stage
Employees
Links
William Conkling
8 members
1 members
Genentech
128 followers
Thermo Fisher Scientific
111 followers
Gilead Sciences
93 followers
Biogen
94 followers
Regeneron
78 followers
Discover companies